Dolby Laboratories (NYSE:DLB – Get Free Report) had its price target decreased by research analysts at Robert W. Baird from $62.00 to $60.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the electronics maker’s stock. Robert W. Baird‘s price objective suggests a potential upside of 8.65% from the stock’s previous close.
DLB has been the topic of several other reports. Zacks Research raised Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, November 13th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Rosenblatt Securities cut their price objective on Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, November 16th. Finally, Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Dolby Laboratories currently has a consensus rating of “Hold” and a consensus price target of $76.67.
Get Our Latest Stock Report on DLB
Dolby Laboratories Trading Up 0.8%
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 17th. The electronics maker reported $1.25 EPS for the quarter, beating the consensus estimate of $1.20 by $0.05. The company had revenue of $373.54 million during the quarter, compared to analysts’ expectations of $372.76 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. The firm’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.99 EPS. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, research analysts predict that Dolby Laboratories will post 3.36 earnings per share for the current year.
Dolby Laboratories declared that its board has approved a stock buyback program on Thursday, July 30th that allows the company to buy back $350 million in outstanding shares. This repurchase authorization allows the electronics maker to reacquire up to 7% of its shares through open market purchases. Stock repurchase programs are generally an indication that the company’s management believes its shares are undervalued.
Insider Buying and Selling
In other Dolby Laboratories news, SVP John Couling sold 7,667 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total transaction of $450,666.26. Following the sale, the senior vice president directly owned 166,803 shares in the company, valued at $9,804,680.34. The trade was a 4.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ryan Nicholson sold 1,183 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares of the company’s stock, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 16,517 shares of company stock valued at $995,963. 37.93% of the stock is owned by insiders.
Hedge Funds Weigh In On Dolby Laboratories
Several large investors have recently modified their holdings of the stock. Hsbc Holdings PLC increased its holdings in shares of Dolby Laboratories by 396.1% in the 1st quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock worth $1,875,000 after acquiring an additional 24,958 shares during the period. Pacer Advisors Inc. boosted its stake in Dolby Laboratories by 8.0% during the 1st quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock valued at $31,008,000 after purchasing an additional 38,389 shares during the period. Entropy Technologies LP acquired a new position in Dolby Laboratories during the 1st quarter valued at about $1,674,000. Wellington Management Group LLP boosted its stake in Dolby Laboratories by 19.4% during the 2nd quarter. Wellington Management Group LLP now owns 320,156 shares of the electronics maker’s stock valued at $16,834,000 after purchasing an additional 52,053 shares during the period. Finally, Public Employees Retirement System of Ohio bought a new position in Dolby Laboratories in the 2nd quarter worth about $951,000. Institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
